We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Balanced Reporting. Trusted Insights.
Saturday, May 28, 2022
The Food and Drug Administration is pushing back against a Memorandum of Understanding released Tuesday and designed to divide regulatory authority over genetically-engineered animals between USDA and FDA.
The Food and Drug Administration must evaluate the risks posed if genetically engineered salmon escape into the wild, a federal judge said in a case involving FDA’s 2015 approval of AquaBounty’s plans to create and farm GE Atlantic salmon.